Document:

Exhibit 10.2

 

English Summary
of Supplement to Lease Agreement Dated December 31, 2021

 

 

A supplement dated December 31, 2021 (the
“Supplement”) made to the existing lease agreement dated January 22, 2003 (the “Lease Agreement”)

 

	1.	Parties:
Pluristem Ltd. (“Pluristem”) and MTM – Scientific Industries Center Haifa Ltd. (“MTM”).

 

	2.	Signing
Date: December 31, 2021

 

	3.	The
Premises: Certain areas in Building 5.1 (approximately 4,389 square meters in total of office space – “Office
Space”) and a certain areas in Building 5.1 (approximately 191 square meters in total – “Area”), and 87 parking
spots in different locations, all in MATAM Advanced Technology Park, Haifa, Israel (the “Premises”). The Parties agree
that the Area will be measured again, and in the case of measurement inaccuracy, the fees will be retroactively adjusted to the correct
measures.

 

	4.	Lease
Period: The Supplement extends the rent period with respect to the Premises until December 31, 2026 (the “Lease Period”).
Notwithstanding the foregoing, Pluristem has a right to extend the Lease Agreement for an additional sixty (60) more calendar months
until December 31, 2031 upon providing 6 months’ advanced written notice prior to the end of the Lease Period, and as long as Pluristem
is not in material breach of the Lease Agreement (the “Option Period”).

 

	5.	Lease
Fees: Lease fees are payable monthly in the following amounts (linked to the Israeli Consumer Price Index as of September 2014):

 

		5.1	For
the leased Office Space in Building 20, 65 New Israeli Shekel (NIS) per one square meter (plus applicable taxes);

 

		5.2	For
the leased Area space in Building 20, 33 New Israeli Shekel (NIS) per one square meter (plus applicable taxes);

 

		5.3	During
the Option Period, the fees for the Office Space will be increased by 10% to 71.5 NIS per one square meter, and 36.3 NIS per one square
meter of the Area (plus applicable taxes);

 

		5.4	During
the Lease Period, the fees for each parking spot will differ: (1) during the period between January 1, 2022 to December 31, 2022 –
300 NIS (plus applicable taxes) per parking spot, (2) during the period between January 1, 2023 to December 31, 2024 – 350 NIS
(plus applicable taxes) per parking spot, (3) during the period between January 1, 2024 to December 31, 2026 – 400 NIS (plus applicable
taxes) per parking spot. During the Option Period, the price per parking spot will increase by 10% from the last paid price, to 440 NIS
per parking spot;

 

		5.5	Management
fees during the extended Lease Period will be calculated using the cost+15% mechanism. The estimated management fees on the date of signing
of this Supplement are 4 NIS for each 1 square meter of the Office Space, not including the Area (plus applicable taxes);

 

		5.6	All
fees will be linked to the base index as defined in the Supplement, and will include VAT.

 

	6.	Leasehold
Improvements: Pluristem will make improvements to the pump room on the Premises, and MTM will participate in the payment of these
improvements in an amount that would not exceed 100,000 NIS plus applicable taxes.

 

	7.	Guarantees:
In order to secure its undertakings under this agreement, Pluristem shall provide MTM within no more than 30 days from signing this Supplement,
an updated unconditional autonomic bank guarantee in an amount equal to 6 months lease fees (calculated for the new fees) (plus applicable
taxes). If the option to extend the lease is exercised, the guarantee amount should be increased to include the applicable fees.

 

	8.	Transfer
of Rights: Pluristem will be allowed to rent out parts of the Premises, only on the second floor of the building, following 21
days’ notice to MTM, and provided that the subleasor accepts all of the obligations under the original Lease Agreement. The subleasor
must also sign a guarantee in favor of MTM and is only allowed to use the Premises for permitted purposes.

 

	9.	Management
and Services: MTM will provide building management services through MTM or a management company.

 

Subject to the arrangements under the Supplement, all the provisions
of the Lease Agreement shall apply to the Supplement.Exhibit 10.1

 

FORM OF VOTING
AGREEMENT

 

This Voting Agreement (this
“Agreement”) is made as of February 2, 2022 by and among (i) Edoc Acquisition Corp., a Cayman Islands
exempted company (together with its successors, including its successor after the Conversion (as such term is defined in the Merger Agreement,
as defined below), the “Purchaser”), (ii) Calidi Biotherapeutics, Inc., a Nevada corporation (the “Company”),
and (iii) the undersigned stockholder (“Holder”) of the Company. Any capitalized term used but not defined in
this Agreement will have the meaning ascribed to such term in the Merger Agreement.

 

WHEREAS, on the date
hereof, the Purchaser, the Company, EDOC Merger Sub Inc., a Nevada corporation and a wholly-owned subsidiary of the Purchaser (“Merger
Sub”), and the other parties named therein, have entered into that certain Agreement and Plan of Merger (as amended from
time to time in accordance with the terms thereof, the “Merger Agreement”), pursuant to which Merger Sub will
merge with and into the Company, with the Company continuing as the surviving entity (the “Merger”), and as
a result of which, among other matters, all of the issued and outstanding capital stock of the Company as of the Effective Time shall
no longer be outstanding and shall automatically be cancelled and shall cease to exist, in exchange for the right to receive Stockholder
Merger Consideration as set forth in the Merger Agreement, all upon the terms and subject to the conditions set forth in the Merger Agreement
and in accordance with the applicable provisions of the DGCL;

 

WHEREAS, the Board
of Directors of the Company has (a) approved and declared advisable the Merger Agreement, the Ancillary Documents, the Merger and the
other transactions contemplated by any such documents (collectively, the “Transactions”), (b) determined that
the Transactions are fair to and in the best interests of the Company and its stockholders (the “Company Stockholders”)
and (c) recommended the approval and the adoption by each of the Company Stockholders of the Merger Agreement, the Ancillary Documents,
the Merger and the other Transactions; and

 

WHEREAS, as a condition
to the willingness of the Purchaser to enter into the Merger Agreement, and as an inducement and in consideration therefor, and in view
of the valuable consideration to be received by Holder thereunder, and the expenses and efforts to be undertaken by the Purchaser and
the Company to consummate the Transactions, the Purchaser, the Company and Holder desire to enter into this Agreement in order for Holder
to provide certain assurances to the Purchaser regarding the manner in which Holder is bound hereunder to vote any shares of capital stock
of the Company which Holder beneficially owns, holds or otherwise has voting power (the “Shares”) during the
period from and including the date hereof through and including the date on which this Agreement is terminated in accordance with its
terms (the “Voting Period”) with respect to the Merger Agreement, the Merger, the Ancillary Documents and the
Transactions.

 

NOW, THEREFORE, in
consideration of the premises set forth above, which are incorporated in this Agreement as if fully set forth below, and intending to
be legally bound hereby, the parties hereby agree as follows:

 

1.
Covenant to Vote in Favor of Transactions. Holder agrees, with respect to all of the Shares:

 

(a)
during the Voting Period, at each meeting of the Company Stockholders or any class or series thereof, and in each written consent
or resolutions of any of the Company Stockholders in which Holder is entitled to vote or consent, Holder hereby unconditionally and irrevocably
agrees to be present for such meeting and vote (in person or by proxy), or consent to any action by written consent or resolution with
respect to, as applicable, the Shares (i) in favor of, and adopt, the Merger, the Merger Agreement, the Ancillary Documents, any amendments
to the Company’s Organizational Documents, and all of the other Transactions (and any actions required in furtherance thereof),
(ii) in favor of the other matters set forth in the Merger Agreement, and (iii) to vote the Shares in opposition to: (A) any Acquisition
Proposal and any and all other proposals (x) for the acquisition of the Company, (y) that could reasonably be expected to delay or impair
the ability of the Company to consummate the Merger, the Merger Agreement or any of the Transactions, or (z) which are in competition
with or materially inconsistent with the Merger Agreement or the Ancillary Documents; (B) other than as contemplated by the Merger Agreement
any material change in (x) the present capitalization of the Company or any amendment of the Company’s Organizational Documents
other than as reasonably necessary in order to satisfy the conditions to the Closing of the Merger Agreement, or (y) the Company’s
corporate structure or business; or (C) any other action or proposal involving any Target Company that is intended, or would reasonably
be expected, to prevent, impede, interfere with, delay, postpone or adversely affect in any material respect the Transactions or would
reasonably be expected to result in any of the conditions to the Closing under the Merger Agreement not being fulfilled;

 

     

     

    

 

(b)
to execute and deliver all related documentation and take such other action in support of the Merger, the Merger Agreement, any
Ancillary Documents and any of the Transactions as shall reasonably be requested by the Company or the Purchaser in order to carry out
the terms and provision of this Section 1, including, without limitation, (i) execution and delivery to the Company of a Letter
of Transmittal and the Transmittal Documents, (ii) delivery of Holder’s Company Certificate (or a Lost Certificate Affidavit in
lieu of the Company Certificate), duly endorsed for transfer, to the Company and any similar or related documents and such other documents
as may be reasonably requested by the Purchaser, (iii) any actions by written consent of the Company Stockholders presented to Holder,
and (vi) any applicable Ancillary Documents (including, without limitation, a Lock-Up Agreement), customary instruments of conveyance
and transfer, and any consent, waiver, governmental filing, and any similar or related documents;

 

(c)
not to deposit, and to cause their Affiliates not to deposit, except as provided in this Agreement, any Shares owned by Holder
or his/her/its Affiliates in a voting trust or subject any Shares to any arrangement or agreement with respect to the voting of such Shares,
unless specifically requested to do so by the Company and the Purchaser in connection with the Merger Agreement, the Ancillary Documents
and any of the Transactions;

 

(d)
except as contemplated by the Merger Agreement or the Ancillary Documents, make, or in any manner participate in, directly or indirectly,
a “solicitation” of “proxies” or consents (as such terms are used in the rules of the SEC) or powers of attorney
or similar rights to vote, or seek to advise or influence any Person with respect to the voting of, any shares of the Company capital
stock in connection with any vote or other action with respect to the Transactions, other than to recommend that stockholders of the Company
vote in favor of adoption of the Merger Agreement and the Transactions and any other proposal the approval of which is a condition to
the obligations of the parties under the Merger Agreement (and any actions required in furtherance thereof and otherwise as expressly
provided by Section 1 of this Agreement); and

 

(e)
to refrain from exercising any dissenters’ rights or rights of appraisal under applicable law at any time with respect to
the Merger, the Merger Agreement, the Ancillary Documents and any of the Transactions, including pursuant to the DGCL; and

 

(f)  
without limiting Sections 1(a) and 1(b) above, to: (i) approve and consent to and with respect to any Company Preferred Stock held
by Holder participate in, the Company Preferred Stock Exchange and convert all shares of Company Preferred Stock held by Holder for shares
of Company Common Stock at the applicable conversion ratio (including any accrued or declared but unpaid dividends) as set forth in the
Company Charter.

 

    2

     

    

 

2.
 Grant of Proxy. Holder, with respect to all of the Shares, hereby irrevocably grants to, and appoints, Allan J. Camasia
and any designee of Allan J. Camasia (determined in the Company’s sole discretion) as Holder’s attorney-in-fact and proxy,
with full power of substitution and resubstitution, for and in Holder’s name, to vote, or cause to be voted (including by proxy
or written consent, if applicable) any Shares owned (whether beneficially or of record) by Holder. The proxy granted by Holder pursuant
to this Section 2 is irrevocable and is granted in consideration of Allan J. Camasia entering into this Agreement and the Merger
Agreement and incurring certain related fees and expenses. Holder hereby affirms that such irrevocable proxy is coupled with an interest
by reason of the Merger Agreement and, except upon the termination of this Agreement in accordance with Section 5(a), is intended
to be irrevocable. Holder agrees, until this Agreement is terminated in accordance with Section 5(a), to vote its Shares in accordance
with Section 1 above.

 

3.
Other Covenants. 

 

(a)
No Transfers. Holder agrees that during the Voting Period it shall not, and shall cause its Affiliates not to, without the
Purchaser’s prior written consent, (A) offer for sale, sell (including short sales), transfer, tender, pledge, encumber, assign
or otherwise dispose of (including by gift) (collectively, a “Transfer”), or enter into any contract, option,
derivative, hedging or other agreement or arrangement or understanding (including any profit-sharing arrangement) with respect to, or
consent to, a Transfer of, any or all of the Shares; (B) grant any proxies or powers of attorney with respect to any or all of the Shares;
(C) permit to exist any lien of any nature whatsoever (other than those imposed by this Agreement, applicable securities Laws or the Company’s
Organizational Documents, as in effect on the date hereof) with respect to any or all of the Shares; or (D) take any action that would
have the effect of preventing, impeding, interfering with or adversely affecting Holder’s ability to perform its obligations under
this Agreement. The Company hereby agrees that it shall not permit any Transfer of the Shares in violation of this Agreement. Holder agrees
with, and covenants to, the Purchaser that Holder shall not request that the Company register the Transfer (book-entry or otherwise) of
any certificate or uncertificated interest representing any Shares during the term of this Agreement without the prior written consent
of the Purchaser, and the Company hereby agrees that it shall not effect any such Transfer.

 

(b)
Permitted Transfers. Section 3(a) shall not prohibit a Transfer of Shares by Holder (i) to any family member or trust
for the benefit of any family member, (ii) to any stockholder, member or partner of Holder, if an entity, (iii) to any Affiliate of Holder,
or (iv) to any person or entity if and to the extent required by any non-consensual Order, by divorce decree or by will, intestacy or
other similar Applicable Law, so long as, in the case of the foregoing clauses (i), (ii) and (iii), the assignee or transferee agrees
to be bound by the terms of this Agreement and executes and delivers to the parties hereto a written consent and joinder memorializing
such agreement. During the term of this Agreement, the Company will not register or otherwise recognize the transfer (book-entry or otherwise)
of any Shares or any certificate or uncertificated interest representing any of Holder’s Shares, except as permitted by, and in
accordance with, this Section 3(b).

 

(c)
Changes to Shares. In the event of a stock dividend or distribution, or any change in the shares of capital stock of the
Company by reason of any stock dividend or distribution, stock split, recapitalization, combination, conversion, exchange of shares or
the like, the term “Shares” shall be deemed to refer to and include the Shares as well as all such stock dividends and distributions
and any securities into which or for which any or all of the Shares may be changed or exchanged or which are received in such transaction.
Holder agrees during the Voting Period to notify the Purchaser and the Company promptly in writing of the number and type of any additional
Shares acquired by Holder, if any, after the date hereof.

 

    3

     

    

 

(d)
Compliance with Merger Agreement. Holder agrees to not during the Voting Period take or agree or commit to take any action
that would make any representation and warranty of Holder contained in this Agreement inaccurate in any material respect. Holder further
agrees that it shall use its commercially reasonable efforts to cooperate with the Purchaser to effect the Merger, all other Transactions,
the Merger Agreement, the Ancillary Documents and the provisions of this Agreement. During the Voting Period, Holder shall not authorize
or permit any of its Representatives to, directly or indirectly, take any action that the Company is prohibited from taking pursuant to
Section 5.2 of the Merger Agreement (unless the Purchaser shall have consented thereto).

 

(e)
Registration Statement. During the Voting Period, Holder agrees to provide to the Purchaser, the Company and their respective
Representatives any information regarding Holder or the Shares that is reasonably requested by the Purchaser, Company or their respective
Representatives for inclusion in the Registration Statement.

 

(f)  
Publicity. Holder shall not issue any press release or otherwise make any public statements with respect to the Transactions
or the transactions contemplated herein without the prior written approval of the Company and the Purchaser. Holder hereby authorizes
the Company and the Purchaser to publish and disclose in any announcement or disclosure required by the SEC, Nasdaq or the Registration
Statement (including all documents and schedules filed with the SEC in connection with the foregoing), Holder’s identity and ownership
of the Shares and the nature of Holder’s commitments and agreements under this Agreement, the Merger Agreement and any other Ancillary
Documents.

 

4.
Representations and Warranties of Holder. Holder hereby represents and warrants to the Purchaser and the Company
as follows:

 

(a)
Binding Agreement. Holder (i) if a natural person, is of legal age to execute this Agreement and is legally competent to
do so and (ii) if not a natural person, is (A) a corporation, limited liability company, company or partnership duly organized and validly
existing under the laws of the jurisdiction of its organization and (B) has all necessary power and authority to execute and deliver this
Agreement, to perform its obligations hereunder and to consummate the transactions contemplated hereby. If Holder is not a natural person,
the execution and delivery of this Agreement, the performance of its obligations hereunder and the consummation of the transactions contemplated
hereby by Holder has been duly authorized by all necessary corporate, limited liability or partnership action on the part of Holder, as
applicable. This Agreement, assuming due authorization, execution and delivery hereof by the other parties hereto, constitutes a legal,
valid and binding obligation of Holder, enforceable against Holder in accordance with its terms (except as such enforceability may be
limited by bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other similar laws of general applicability relating
to or affecting creditor’s rights, and to general equitable principles). Holder understands and acknowledges that the Purchaser
is entering into the Merger Agreement in reliance upon the execution and delivery of this Agreement by Holder.

 

(b)
Ownership of Shares. As of the date hereof, Holder has beneficial ownership over the type and number of the Shares set forth
under Holder’s name on the signature page hereto, is the lawful owner of such Shares, has the sole power to vote or cause to be
voted such Shares, and has good and valid title to such Shares, free and clear of any and all pledges, mortgages, encumbrances, charges,
proxies, voting agreements, liens, adverse claims, options, security interests and demands of any nature or kind whatsoever, other than
those imposed by this Agreement, applicable securities Laws or the Company’s Organizational Documents, as in effect on the date
hereof. There are no claims for finder’s fees or brokerage commission or other like payments in connection with this Agreement or
the transactions contemplated hereby payable by Holder pursuant to arrangements made by Holder. Except for the Shares and other securities
of the Company set forth under Holder’s name on the signature page hereto, as of the date of this Agreement, Holder is not a beneficial
owner or record holder of any: (i) equity securities of the Company, (ii) securities of the Company having the right to vote on any matters
on which the holders of equity securities of the Company may vote or which are convertible into or exchangeable for, at any time, equity
securities of the Company or (iii) options, warrants or other rights to acquire from the Company any equity securities or securities convertible
into or exchangeable for equity securities of the Company.

 

    4

     

    

 

(c)
No Conflicts. No filing with, or notification to, any Governmental Authority, and no consent, approval, authorization or
permit of any other person is necessary for the execution of this Agreement by Holder, the performance of its obligations hereunder or
the consummation by it of the transactions contemplated hereby. None of the execution and delivery of this Agreement by Holder, the performance
of its obligations hereunder or the consummation by it of the transactions contemplated hereby shall (i) conflict with or result in any
breach of the certificate of incorporation, bylaws or other comparable organizational documents of Holder, if applicable, (ii) result
in, or give rise to, a violation or breach of or a default under any of the terms of any Contract or obligation to which Holder is a party
or by which Holder or any of the Shares or its other assets may be bound, or (iii) violate any applicable Law or Order, except for any
of the foregoing in clauses (i) through (iii) as would not reasonably be expected to impair Holder’s ability to perform its obligations
under this Agreement in any material respect.

 

(d)
No Inconsistent Agreements. Holder hereby covenants and agrees that, except for this Agreement, Holder (i) has not entered
into, nor will enter into at any time while this Agreement remains in effect, any voting agreement or voting trust with respect to the
Shares inconsistent with Holder’s obligations pursuant to this Agreement, (ii) has not granted, nor will grant at any time while
this Agreement remains in effect, a proxy, a consent or power of attorney with respect to the Shares and (iii) has not entered into any
agreement or knowingly taken any action (nor will enter into any agreement or knowingly take any action) that would make any representation
or warranty of Holder contained herein untrue or incorrect in any material respect or have the effect of preventing Holder from performing
any of its material obligations under this Agreement.

 

5.
Miscellaneous.

 

(a)
Termination. Notwithstanding anything to the contrary contained herein, this Agreement shall automatically terminate, and
none of the Purchaser, the Company or Holder shall have any rights or obligations hereunder, upon the earliest to occur of (i) the mutual
written consent of the Purchaser, the Company and Holder, (ii) the Effective Time (following the performance of the obligations of the
parties hereunder required to be performed at or prior to the Effective Time), and (iii) the date of termination of the Merger Agreement
in accordance with its terms. The termination of this Agreement shall not prevent any party hereunder from seeking any remedies (at law
or in equity) against another party hereto or relieve such party from liability for such party’s breach of any terms of this Agreement.
Notwithstanding anything to the contrary herein, the provisions of this Section 5(a) shall survive the termination of this Agreement. 

 

(b)
Binding Effect; Assignment. This Agreement and all of the provisions hereof shall be binding upon and inure to the benefit
of the parties hereto and their respective permitted successors and assigns. This Agreement and all obligations of Holder are personal
to Holder and may not be assigned, transferred or delegated by Holder at any time without the prior written consent of the Purchaser and
the Company, and any purported assignment, transfer or delegation without such consent shall be null and void ab initio. Each of the Company
and the Purchaser may freely assign any or all of its rights under this Agreement, in whole or in part, to any successor entity (whether
by merger, consolidation, equity sale, asset sale or otherwise) without obtaining the consent or approval of Holder.

 

(c)
Third Parties. Nothing contained in this Agreement or in any instrument or document executed by any party in connection
with the transactions contemplated hereby shall create any rights in, or be deemed to have been executed for the benefit of, any person
that is not a party hereto or thereto or a successor or permitted assign of such a party.

 

    5

     

    

 

(d)
Governing Law; Jurisdiction. This Agreement and any dispute or controversy arising out of or relating to this Agreement
shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to the conflict of law principles
thereof. All Actions arising out of or relating to this Agreement shall be heard and determined exclusively in any state or federal court
located in New York, New York (or in any appellate courts thereof) (the “Specified Courts”). Each party hereto
hereby (i) submits to the exclusive jurisdiction of any Specified Court for the purpose of any Action arising out of or relating
to this Agreement brought by any party hereto and (ii) irrevocably waives, and agrees not to assert by way of motion, defense or
otherwise, in any such Action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property
is exempt or immune from attachment or execution, that the Action is brought in an inconvenient forum, that the venue of the Action is
improper, or that this Agreement or the transactions contemplated hereby may not be enforced in or by any Specified Court. Each party
agrees that a final judgment in any Action shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in
any other manner provided by Law. Each party irrevocably consents to the service of the summons and complaint and any other process in
any other action or proceeding relating to the transactions contemplated by this Agreement, on behalf of itself, or its property, by personal
delivery of copies of such process to such party at the applicable address set forth or referred to in Section 5(g). Nothing
in this Section 5(d) shall affect the right of any party to serve legal process in any other manner permitted by applicable
law.

 

(e)
WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT
IT MAY HAVE TO A TRIAL BY JURY WITH RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT
OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH PARTY HERETO (i) CERTIFIES THAT NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY
OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF ANY ACTION, SEEK TO ENFORCE THAT FOREGOING WAIVER AND (ii) ACKNOWLEDGES
THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS
IN THIS SECTION 5(e).

 

(f) Interpretation. The
titles and subtitles used in this Agreement are for convenience only and are not to be considered in construing or interpreting this
Agreement. In this Agreement, unless the context otherwise requires: (i) any pronoun used in this Agreement shall include the corresponding
masculine, feminine or neuter forms, and the singular form of nouns, pronouns and verbs shall include the plural and vice versa; (ii)
“including” (and with correlative meaning “include”) means including without limiting the generality of any description
preceding or succeeding such term and shall be deemed in each case to be followed by the words “without limitation”; (iii)
the words “herein,” “hereto,” and “hereby” and other words of similar import in this Agreement shall
be deemed in each case to refer to this Agreement as a whole and not to any particular section or other subdivision of this Agreement;
and (iv) the term “or” means “and/or”. The parties have participated jointly in the negotiation and drafting
of this Agreement. Consequently, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed
as if drafted jointly by the parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue
of the authorship of any provision of this Agreement.

 

    6

     

    

 

(g) Notices.
All notices, consents, waivers and other communications hereunder shall be in writing and shall be deemed to have been duly given when
delivered (i) in person, (ii) by facsimile or other electronic means, with affirmative confirmation of receipt, (iii) one Business Day
after being sent, if sent by reputable, nationally recognized overnight courier service or (iv) three (3) Business Days after being mailed,
if sent by registered or certified mail, pre-paid and return receipt requested, in each case to the applicable party at the following
addresses (or at such other address for a party as shall be specified by like notice):

 

	
    If to the Purchaser, to:

     

    Edoc Acquisition Corp.

    7612 Main Street Fishers, Suite 200

    Victor, New York 14564

    Attn: Kevin Chen

    Telephone No.: (585) 678-1198

    Email: kevin.chen@edocmed.net
	
    with a copy (which will not constitute notice) to:

     

    Ellenoff Grossman & Schole LLP

    1345 Avenue of the Americas, 11th Floor

    New York, New York 10105

    Attn: Barry I. Grossman, Esq.

    Facsimile No.: (212) 370-7889

    Telephone No.: (212) 370-1300

    Email: bigrossman@egsllp.com

	
    If to the Company, to:

     

    Calidi Biotherapeutics, Inc.

    11011 North Torrey Pines Road, Suite 200

    La Jolla, CA 92037

    Attn: Allan Camaisa, Chairman and CEO

    Facsimile No.: (858) 794-9605

    Telephone No.: (858) 794-9600

    Email: acamaisa@calidibio.com
	
    with a copy (which will not constitute notice) to:

     

    Lewis Brisbois Bisgaard & Smith LLP

    633 West 5th Street, Suite 4000

    Los Angeles, CA 90071

    Attn: Scott E. Bartel

    Facsimile No.: (916) 564-5444

    Telephone No.: (916) 646-8228

    Email: scott.bartel@LewisBrisbois.com

	If to Holder, to: the address set forth under Holder’s name on the signature page hereto, with a copy (which will not constitute notice) to, if not the party sending the notice, each of the Company and the Purchaser (and each of their copies for notices hereunder).

 

(h)
Amendments and Waivers. Any term of this Agreement may be amended and the observance of any term of this Agreement may be
waived (either generally or in a particular instance, and either retroactively or prospectively) only with the written consent of the
Purchaser, the Company and the Holder. No failure or delay by a party in exercising any right hereunder shall operate as a waiver thereof.
No waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be
or construed as a further or continuing waiver of any such term, condition, or provision.

 

(i) Severability. In
case any provision in this Agreement shall be held invalid, illegal or unenforceable in a jurisdiction, such provision shall be modified
or deleted, as to the jurisdiction involved, only to the extent necessary to render the same valid, legal and enforceable, and the validity,
legality and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby nor shall the validity,
legality or enforceability of such provision be affected thereby in any other jurisdiction. Upon such determination that any term or
other provision is invalid, illegal or incapable of being enforced, the parties will substitute for any invalid, illegal or unenforceable
provision a suitable and equitable provision that carries out, so far as may be valid, legal and enforceable, the intent and purpose
of such invalid, illegal or unenforceable provision.

 

    7

     

    

 

(j) Specific Performance.
Holder acknowledges that its obligations under this Agreement are unique, recognizes and affirms that in the event of a breach of this
Agreement by Holder, money damages will be inadequate and the Company and the Purchaser will have not adequate remedy at law, and agree
that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed by Holder in accordance
with their specific terms or were otherwise breached. Accordingly, the Company and the Purchaser shall be entitled to an injunction or
restraining order to prevent breaches of this Agreement by Holder and to enforce specifically the terms and provisions hereof, without
the requirement to post any bond or other security or to prove that money damages would be inadequate, this being in addition to any
other right or remedy to which such party may be entitled under this Agreement, at law or in equity.

 

(k)
Expenses. Each party shall be responsible for its own fees and expenses (including the fees and expenses of investment bankers,
accountants and counsel) in connection with the entering into of this Agreement, the performance of its obligations hereunder and the
consummation of the transactions contemplated hereby; provided, that in the event of any Action arising out of or relating to this Agreement,
the non-prevailing party in any such Action will pay its own expenses and the reasonable documented out-of-pocket expenses, including
reasonable attorneys’ fees and costs, reasonably incurred by the prevailing party.

 

(l) No Partnership,
Agency or Joint Venture. This Agreement is intended to create a contractual relationship among Holder, the Company and the Purchaser,
and is not intended to create, and does not create, any agency, partnership, joint venture or any like relationship among the parties
hereto or among any other Company shareholders entering into voting agreements with the Company or the Purchaser. Holder is not affiliated
with any other holder of securities of the Company entering into a voting agreement with the Company or the Purchaser in connection with
the Merger Agreement and has acted independently regarding its decision to enter into this Agreement. Nothing contained in this Agreement
shall be deemed to vest in the Company or the Purchaser any direct or indirect ownership or incidence of ownership of or with respect
to any Shares.

 

(m)  
Further Assurances. From time to time, at another party’s request and without further consideration, each party shall
execute and deliver such additional documents and take all such further action as may be reasonably necessary or desirable to consummate
the transactions contemplated by this Agreement.

 

(n)
Entire Agreement. This Agreement (together with the Merger Agreement to the extent referred to herein) constitutes the full
and entire understanding and agreement among the parties with respect to the subject matter hereof, and any other written or oral agreement
relating to the subject matter hereof existing between the parties is expressly canceled; provided, that, for the avoidance
of doubt, the foregoing shall not affect the rights and obligations of the parties under the Merger Agreement or any Ancillary Document.
Notwithstanding the foregoing, nothing in this Agreement shall limit any of the rights or remedies of the Purchaser or any of the obligations
of Holder under any other agreement between Holder and the Purchaser or any certificate or instrument executed by Holder in favor of the
Purchaser, and nothing in any other agreement, certificate or instrument shall limit any of the rights or remedies of the Purchaser or
any of the obligations of Holder under this Agreement.

 

(o)
Counterparts; Facsimile. This Agreement may also be executed and delivered by facsimile or electronic signature or by email
in portable document format in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute
one and the same instrument.

 

[Remainder of Page Intentionally Left Blank;
Signature Page Follows]

 

    8

     

    

 

IN WITNESS WHEREOF, the parties have executed
this Voting Agreement as of the date first written above.

 

	 	The Purchaser:
	 	 
	 	EDOC ACQUISITION CORP.
	 	 	 
	 	By:	
	 	Name: 	Kevin Chen
	 	Title:	Chief Executive Officer
	 	 	 
	 	The Company:
	 	 
	 	CALIDI BIOTHERAPEUTICS, INC.
	 	 	                                    
	 	By:	
	 	Name:	Allan Camaisa
	 	Title:	Chairman and Chief Executive Officer

 

	Holder:	 
	 	 	 
	By:	 	 
	Name:	 	 

 

Number and Type of Shares:

 

__________ shares of Company Common Stock

 

[__________ shares of Company Preferred Stock]

 

Address for Notice:  

 

	Address:	 	 
	 	 	 
	 	 
	 	 
	 	 	 
	Facsimile No.:	 	 
	Telephone No.:	 	 
	Email:	 	:

 

{Signature Page to Voting Agreement}

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}]]